SPNS2 and triple-negative breast carcinoma: GUSBP11 also enhances the expression of sphingolipid transporter 2 (SPNS2) in triple-negative breast cancer cell lines and suppresses the malignancy of triple-negative breast cancer cells by sponging miR-579-3p.